Jump Financial, LLC Seres Therapeutics, Inc. Transaction History

Jump Financial, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.7 - $1.48 $7,165 - $15,149	-10,236 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$0.56 - $1.19 $5,732 - $12,180	10,236 New	10,236 $7,000
Q2 2023 Oct 21, 2024	BUY	$4.67 - $6.55 $57,347 - $80,434	12,280 Added 119.97%	22,516 $107,000
Q2 2023 Aug 07, 2023	BUY	$4.67 - $6.55 $105,149 - $147,479	22,516 New	22,516 $107,000
Q4 2022 Feb 13, 2023	BUY	$5.09 - $9.05 $372,252 - $661,862	73,134 New	73,134 $409,000
Q1 2022 May 12, 2022	SELL	$6.3 - $8.84 $166,874 - $234,153	-26,488 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$6.02 - $11.43 $159,457 - $302,757	26,488 New	26,488 $221,000
Q3 2021 Nov 12, 2021	SELL	$5.46 - $22.6 $259,693 - $1.07 Million	-47,563 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$18.46 - $24.36 $374,941 - $494,775	20,311 Added 74.53%	47,563 $1.13 Million
Q1 2021 May 17, 2021	SELL	$17.66 - $28.92 $263,981 - $432,296	-14,948 Reduced 35.42%	27,252 $561,000
Q4 2020 Feb 12, 2021	BUY	$23.25 - $37.73 $981,150 - $1.59 Million	42,200 New	42,200 $1.03 Million

40.5M

304K

471K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $95.5M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.